These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 11593335)

  • 61. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
    Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
    Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS; Sabo P; Adman ET; Black ME
    Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multi-log cytotoxicity of carbocyclic 2'-deoxyguanosine in HSV-TK-expressing human tumor cells.
    Shewach DS; Murphy PJ; Robinson BW; Vuletich J; Boucher PD; Blobaum AL; Zerbe L; Secrist JA; Parker WB
    Hum Gene Ther; 2002 Mar; 13(4):543-51. PubMed ID: 11874632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
    Oldfield EH; Ram Z; Culver KW; Blaese RM; DeVroom HL; Anderson WF
    Hum Gene Ther; 1993 Feb; 4(1):39-69. PubMed ID: 8384892
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
    Boucher PD; Im MM; Freytag SO; Shewach DS
    Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
    Wang JH; Situ ZQ; Wu JZ; Liu B
    Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer.
    Atkinson G; Hall SJ
    Urology; 1999 Dec; 54(6):1098-104. PubMed ID: 10604717
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Ganciclovir induces apoptosis of rat C6 glioma cell transduced with HSV-tk gene].
    Ma W; Chen S; Ren Z; Wang W; Zhang J; Su C; Wang R; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):165-9. PubMed ID: 12903520
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells.
    Beck C; Cayeux S; Lupton SD; Dörken B; Blankenstein T
    Hum Gene Ther; 1995 Dec; 6(12):1525-30. PubMed ID: 8664377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Another mechanism causing the bystander effect besides the gap junction's role during the glioma gene therapy with HSV-TK/GCV system.
    Du L; Bai S; Whittle IR; He L
    Adv Exp Med Biol; 1998; 451():133-8. PubMed ID: 10026862
    [No Abstract]   [Full Text] [Related]  

  • 78. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
    Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
    J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase.
    Kunishige I; Samejima Y; Shiki Y; Moriyama A; Meruelo D; Saji F; Murata Y
    Gynecol Oncol; 1999 Jan; 72(1):16-25. PubMed ID: 9889024
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.